Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Bianca Boff SandiGabriel Stefani LeãoAngelo Alves de MattosÂngelo Zambam de MattosPublished in: Journal of gastroenterology and hepatology (2020)
Long-term albumin administration in patients with cirrhosis and ascites decreases recurrence of ascites/need for paracentesis. At this point, there is no evidence of significant benefits of long-term albumin administration regarding mortality or other complications of cirrhosis.